(1)
Wulandari Harahap, P.; Putra Tarigan, S.; Novisari Soeroso, N. Adverse Event Of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Treatment In Medan Among Pulmonary Adenocarcinoma: Focus On Non-Hematologic Toxicity. IJHP 2025, 5, 422-429.